Teleflex Incorporated(TFX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 8:59 AM ET (Korea 9/11 21:59)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -23.29 | Insider Own | 0.82% | Shs Outstand | 42.4M | Perf Week | -6.36% |
| Market Cap | 5.59B | Forward P/E | 12.05 | EPS next Y | 52.02% | Insider Trans | - | Shs Float | 42.0M | Perf Month | -1.15% |
| Enterprise Value | 8.15B | PEG | 0.6 | EPS next Q | 1.9 | Inst Own | 113.54% | Short Float | 11.5% | Perf Quarter | -0.11% |
| Income | -1.03B | P/S | 2.15 | EPS this Y | 3.22% | Inst Trans | -1.02% | Short Ratio | 9.21 | Perf Half Y | 18.12% |
| Sales | 2.60B | P/B | 1.93 | EPS next 5Y | 20.16% | ROA | -5.3% | Short Interest | 4.84M | Perf YTD | 8.16% |
| Book/sh | 68.55 | P/C | 17.76 | EPS past 3/5Y | - | ROE | -10.51% | 52W High | -8.97% ($145.00) | Perf Year | 1.31% |
| Cash/sh | 7.43 | P/FCF | 16.46 | Sales past 3/5Y | -10.62% -4.72% | ROIC | -18.13% | 52W Low | 31.76% ($100.18) | Perf 3Y | -36.17% |
| Dividend Est. | $1.14 (0.87%) | EV/EBITDA | 18.75 | EPS Y/Y TTM | -644.98% | Gross Margin | 60.89% | Volatility(W/M) | 3.28% 2.89% | Perf 5Y | -64.56% |
| Dividend TTM | 1.36 | EV/Sales | 3.13 | Sales Y/Y TTM | -14.49% | Oper. Margin | 11.02% | ATR (14) | 4.42 | Perf 10Y | -26.88% |
| Dividend Ex-Date | 2026/8/14 | Quick Ratio | 2.12 | EPS Q/Q | -17.42% | Profit Margin | -39.67% | RSI (14) | 39.97 | Recom | 2.44 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.6 | Sales Q/Q | -26.96% | SMA20 | -4.01% ($137.51) | Beta | 0.82 | Target Price | $153.55 |
| Payout | - | Debt/Eq | 0.99 | Earnings | 2026/8/6 | SMA50 | -2.65% ($135.59) | Rel Volume | 1.45 | Prev Close | $135.72 |
| Employees | 15500 | LT Debt/Eq | 0.96 | EPS/Sales Surpr. | 37.36% 1.91% | SMA200 | 6.82% ($123.57) | Avg Volume(3M) | 0.52M | Price | $132 |
| IPO | 1967/4/24 | Option/Short | Yes/Yes | Trades | 10266 | Volume | 760,742 | Change | -2.74% |
Company
TFX is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩺 This is a US medical device company that produces a wide range of medical devices, with a focus on single-use medical devices. It supplies disposable and procedural medical devices used in vascular access, surgery, interventional procedures, urology, and other fields to hospitals. With a high proportion of single-use products that are consumed on a recurring basis, it is a medical device stock that features stable demand and a reliable dividend.
Over the past 1 year, roughly in the middle
9% below its 1-year high.
TFX has weak earning power
11.02% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +3.2% this year.
Tap to view numbers
The stock looks undervalued
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -36.2% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.87% annually in dividends.
Tap to view numbers
Ownership is about average
Institutions hold 113.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
PSCH 0.03%
MDEV 0.02%
BSMC 0.02%
XHE 0.02%
MYHA 0.01%It ranks #4 in the industry
Based on market cap of $6B.
TFX $6B PER -
ISRG $127B PER 41.3
BDX $48B PER 53.2
MDLN $43B PER 38.0
FAQ
What kind of company is TFX?
TFX belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of TFX?
The market cap of TFX is approximately $5.6B, ranking 1,300 within its sector.
Does TFX pay dividends?
TFX has a dividend yield of approximately 0.87%, with an annual dividend of $1.14.
What is the 52-week high and low for TFX?
TFX has recorded a 52-week high of $145.00 and a low of $100.18.
